(KR101684810) Provided are a cellulose ester film and a production method thereof. According to the present invention, the cellulose ester film can increase reliability of cellulose ester phase difference films as well as phase difference films for vertical alignment (VA) under a high temperature and high humidity. To this end, the cellulose ester film of the present invention is produced by including: an asymmetrical ester-based compound which includes an aromatic group is represented by chemical formula 1, T+[D+P]n+D; and a plasticizer which includes a saccharide compound represented by chemical formula 2. COPYRIGHT KIPO 2016
(US20160376167) A method of operating a wastewater vaporization system includes providing wastewater to a flow head at a regulated rate, and operating the flow head to atomize the wastewater into droplets of a calculated size. The calculated size is based on measured environmental conditions.
(KR101684809) The present invention relates to cellulose ester film which is capable of enhancing the high-temperature high-humidity reliability of the cellulose ester phase difference film which can be manufactured into highly reliable retardant film and polarizing plate for VA (Vertical Alignment), and includes a plasticizer of an asymmetric ester compound containing an aromatic group represented by the following formula (1). In this formula, T is a benzene carboxylic acid residue, D is an alkylene glycol residue having 2 to 12 carbon atoms, an aryl glycol residue having 6 to 12 carbon atoms, or an oxyalkylene glycol residue having 4 to 12 carbon atoms, and P is an alkylene dicarboxylic acid residue having 4 to 12 carbon atoms or an aryl dicarboxylic acid residue having 6 to 12 carbon atoms, and n represents an integer of 1 or more. Preferably, the benzene carboxylic acid residue is a toluene acid residue, and the alkylene glycol residue is selected from the group consisting of propylene glycol, neopentyl glycol, diethyleneglycol, dipropyleneglycol, and a triethyleneglycol residue, and the aryl dicarboxylic acid residue is preferably a phthalic acid residue. COPYRIGHT KIPO 2016
(WO2017113288) The present invention relates to Fused Tricyclic Heterocyclic Compounds of Formula (I) :and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Heterocyclic Compound, and methods of using the Fused Tricyclic Heterocyclic Compounds for treating or preventing HIV infection in a subject.